Without voluntary participation of patients in clinical trials, development of new drugs would not be possible. Besides their participation in clinical trials, patients’ engagement is important for various stakeholders in drug development and render their efforts meaningful. Hence, the question is not if the patients’ perspectives should be put at the center of drug development but how?
We are pleased to present five renowned experts in the field who will share their initiatives and ideas when it comes to the patients’ voice in drug development.
The Department of Health Science and Health Policy is looking forward to welcoming all interested listeners.